STING signaling in colorectal adenocarcinoma cells was found to be regulated by HER2 recruitment of AKT1 in a process that disrupted STING signaling and resulted in the inhibition of antiviral defense and the suppression of antitumor immunity (Wu et al. 2019). This evidence concerns the gene STING1 and colorectal adenocarcinoma.